BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15533902)

  • 1. Lack of effect of celecoxib on prostaglandin E2 concentrations in nipple aspirate fluid from women at increased risk of breast cancer.
    Sauter ER; Schlatter L; Hewett J; Koivunen D; Flynn JT
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1745-50. PubMed ID: 15533902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
    Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
    BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. uPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.
    Qin W; Zhu W; Hewett JE; Rottinghaus G; Chen YC; Flynn JT; Kliethermes B; Mannello F; Sauter ER
    BMC Cancer; 2008 Oct; 8():298. PubMed ID: 18922176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib concentration predicts decrease in prostaglandin E2 concentrations in nipple aspirate fluid from high risk women.
    Sauter ER; Qin W; Hewett JE; Ruhlen RL; Flynn JT; Rottinghaus G; Chen YC
    BMC Cancer; 2008 Feb; 8():49. PubMed ID: 18267025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclooxygenase 2 genetic variant -765G>C does not modulate the effects of celecoxib on prostaglandin E2 production.
    Skarke C; Reus M; Schmidt R; Grundei I; Schuss P; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2006 Dec; 80(6):621-32. PubMed ID: 17178263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
    Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
    Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel.
    Csiki I; Morrow JD; Sandler A; Shyr Y; Oates J; Williams MK; Dang T; Carbone DP; Johnson DH
    Clin Cancer Res; 2005 Sep; 11(18):6634-40. PubMed ID: 16166442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.
    Ferrandina G; Ranelletti FO; Legge F; Lauriola L; Salutari V; Gessi M; Testa AC; Werner U; Navarra P; Tringali G; Battaglia A; Scambia G
    Clin Cancer Res; 2003 Oct; 9(12):4324-31. PubMed ID: 14555502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
    Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
    Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer.
    Mannello F; Tonti GA; Medda V; Pederzoli A; Sauter ER
    Cancer Sci; 2008 Nov; 99(11):2160-9. PubMed ID: 18811693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
    Mao JT; Roth MD; Serio KJ; Baratelli F; Zhu L; Holmes EC; Strieter RM; Dubinett SM
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5835-41. PubMed ID: 14676104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
    Leahy KM; Ornberg RL; Wang Y; Zweifel BS; Koki AT; Masferrer JL
    Cancer Res; 2002 Feb; 62(3):625-31. PubMed ID: 11830509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
    Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
    Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
    Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D favorably alters the cancer promoting prostaglandin cascade.
    Qin W; Smith C; Jensen M; Holick MF; Sauter ER
    Anticancer Res; 2013 Sep; 33(9):3861-6. PubMed ID: 24023320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 8-epimer of prostaglandin F(2alpha), a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer.
    Mannello F; Tonti GA; Pagliarani S; Benedetti S; Canestrari F; Zhu W; Qin W; Sauter ER
    Int J Cancer; 2007 May; 120(9):1971-6. PubMed ID: 17266038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.